$INO Recent Headlines Monday's biggest gaining and

New Post Public Reply Private Reply Replies (0) Message Board

Aug 17, 2014 at 10:18 AM

$INO Recent Headlines

Monday's biggest gaining and declining stocks 5:45 p.m. Nov. 30, 2009 - MarketWatch
Inovio, Merck gain; Novavax falls 5:26 p.m. Nov. 20, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 5:25 p.m. Nov. 20, 2009 - MarketWatch
Onyx, Charles River lead drug stocks lower 12:31 p.m. Aug. 5, 2009 - Val Brickates Kennedy
Mylan, Merck, Bayer lead drug stocks higher 10:35 a.m. July 30, 2009 - Val Brickates Kennedy
Drug stocks retreat as Bayer, Inovio jump 11:31 a.m. July 29, 2009 - Val Brickates Kennedy
Inovio to raise $16.2 million from share sale 6:12 a.m. May 16, 2007 - Simon Kennedy
Inovio to sell 4.59 shjares of unit at $3.52 a share 6:06 a.m. May 16, 2007 - Sarah Turner
Monday's biggest stock gainers and decliners 5:07 p.m. March 26, 2007 - MarketWatch
Inovio: DNA delivery technology lifts HIV vaccine potency 6:23 a.m. March 26, 2007 - Sarah Turner
Innovio: DNA delivery technology lifts HIV vaccine potency 6:06 a.m. March 26, 2007 - Steve Goldstein
Inovio Biomedical started at average at Caris & Co. 10:11 a.m. June 2, 2006 - Tomi Kilgore
Inovio study shows benefit of tumor ablation therapy 7:08 a.m. Nov. 18, 2005 - Aude Lagorce
Inovio: Study shows benefit of tumor ablation therapy 7:01 a.m. Nov. 18, 2005 - Steve Goldstein
Updates, advisories and surprises 10:01 p.m. July 13, 2005 - MarketWatch
Inovio receives $2M milestone payment from Merck 6:41 a.m. July 13, 2005 - Kabir Chibber
Inovio Biomedical to get $2M milestone from Merck 6:17 a.m. July 13, 2005 - Steve Goldstein
Inovio to receive option fee, possible milestones 6:06 a.m. May 12, 2005 - Steve Goldstein
Merck exercises option on Inovio antigen deal 6:05 a.m. May 12, 2005 - Steve Goldstein

Insider Buying This Week Dominated by Pharma and Yield Chasers 8:40 a.m. Aug. 16, 2014 - 247WallSt.com
Will Inovio's Deal With Roche Lead To A Cancer Blockbuster? 12:33 p.m. Aug. 15, 2014 - Seeking Alpha
Update: Inovio Earnings 7:08 a.m. Aug. 14, 2014 - Seeking Alpha
Inovio CEO Invests in 250,000 Shares of Company Stock 2:29 p.m. Aug. 13, 2014 - GuruFocus.com
Insider Trading Alert - INO, RSG And PRI Traded By Insiders 10:45 a.m. Aug. 13, 2014 - TheStreet.com
InsiderInsights.com Daily Round Up: 8/12/14 12:40 a.m. Aug. 13, 2014 - Seeking Alpha
Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies 10:43 a.m. Aug. 12, 2014 - Seeking Alpha
Inovio Pharmaceuticals (INO) Marked As A Dead Cat Bounce Stock 10:05 a.m. Aug. 12, 2014 - TheStreet.com
Why Inovio Pharmaceuticals (INO) Stock Is Declining Today 2:55 p.m. Aug. 11, 2014 - TheStreet.com
Inovio Pharmaceuticals' (INO) CEO Joseph Kim on Q2 2014 Results - Earnings Call Transcript 2:48 p.m. Aug. 11, 2014 - Seeking Alpha
10-Q: INOVIO PHARMACEUTICALS, INC. 6:04 a.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Inovio: Excessive Punishment Leads To Buying Opportunity 2:10 p.m. Aug. 6, 2014 - Seeking Alpha
Inovio Data Not A Home Run, But Got Company In Great Scoring Position 12:40 p.m. July 25, 2014 - Seeking Alpha
Biotech Stock Mailbag: Intercept Pharma, Inovio 7:31 a.m. July 25, 2014 - TheStreet.com
'Mad Money' Lightning Round: Buy, Buy, Buy United Technologies 6:00 a.m. July 25, 2014 - TheStreet.com
Cramer's Lightning Round - What's Up With Tupperware? (7/24/14) 5:54 a.m. July 25, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: You Must Own Facebook 8:05 p.m. July 24, 2014 - TheStreet.com
Ho-Hum, Another Boring Day of Little Volume in the Markets 5:38 p.m. July 24, 2014 - TheStreet.com
Perilous Reversal Stock: Inovio Pharmaceuticals (INO) 9:53 a.m. July 24, 2014 - TheStreet.com
The S&P 500 Closes at Yet Another All-Time Closing High on No Volume 5:34 p.m. July 23, 2014 - TheStreet.com

Inovio Pharmaceuticals Reports 2014 Second Quarter Financial Results 8:30 a.m. Aug. 11, 2014 - PR Newswire - PRF
INOVIO PHARMACEUTICALS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Inovio Pharmaceuticals, Inc. 5:16 p.m. Aug. 6, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 8:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 9:15 a.m. July 23, 2014 - PR Newswire - PRF
Biotech Stocks Highlight -- Research on Celgene, Inovio Pharma, Amgen, and Array BioPharma 6:40 a.m. July 9, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Added To Russell Global, Russell 2000® and Russell Microcap® Indexes 4:00 a.m. July 1, 2014 - PR Newswire - PRF
Biotechnology Equities Technical Notes -- Research on StemCells, Gilead Sciences, Galena Biopharma, and Inovio Pharma 7:10 a.m. June 26, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Initiates Cervical Cancer Clinical Trial 4:00 a.m. June 23, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Broadens its Intellectual Property Portfolio from the University of Pennsylvania 4:00 a.m. June 17, 2014 - PR Newswire - PRF
Theralase's Cancer Technology Demonstrates Vaccine-Like Properties 8:04 a.m. June 16, 2014 - ACCESSWIRE
Inovio Pharmaceuticals to Present at Upcoming Healthcare Conferences 4:00 a.m. June 16, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Clarifies Facts of its VGX-3100 Phase II Trial and Immunotherapy Technology 9:00 a.m. June 11, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Initiates Immune Therapy Trial for Head & Neck Cancer Caused by HPV 4:00 a.m. June 10, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Announces Reverse Stock Split Date 4:00 a.m. May 30, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Breakthrough DNA-Based Monoclonal Antibody Therapy Completely Protects Animals From Lethal Viral Challenge 4:00 a.m. May 27, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Subsidiary Sells Animal Health Assets 4:00 a.m. May 27, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Announces 1 For 4 Reverse Split 4:00 a.m. May 23, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals to Present at Jefferies 2014 Global Healthcare Conference 4:00 a.m. May 21, 2014 - PR Newswire - PRF
Pre-Market Pulse on Top Gainers -- Research on Inovio Pharma, Novavax, FreeSeas, and ImmunoCellular Therapeutics 11:05 a.m. May 20, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis 4:00 a.m. May 13, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

USPS Honors 150 Years of the U.S. Coast Guard Academy

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Damp or Dry: The Battle for Healthy Air in Colorado

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

OneOdio Showcases Innovation at IFA 2026 in Berlin

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Ajman Spotlights Tourism at Arabian Travel Market 2026

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

SMPL Faces Legal Drama: What Investors Need to Know

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

U.S. Green Beret's Mission: Clearing Landmines in Ukraine

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

PureHealth's Acid Reflux Solutions: An Investor's Insight

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...